Department Overview The OHSU Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment.Driven by its mission to end cancer as we know it, the institute is building upon its expertise in targeted treatments for cancer as well as to advance the early detection of cancer when the disease is most treatable.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion.Our Mission is to enable our customers to make the world healthier, cleaner and safer.

Position Description: This position is a member of the Computational Biology Program and will support Oregon Health & Science University investigators in the conduct of original research in service to OHSUs mission to improve human health.Key responsibilities include building and leveraging platform-based tools and biological understanding while working in a team-oriented environment to perform data processing, data analysis and software development.

The Company: Flagship Pioneering has launched a privately held, biotechnology company that is pioneering novel diagnostics for cancer.This new company (FL67) is a highly dynamic, entrepreneurial, and innovation-driven organization seeking to hire a Head of Computational Biology to join our team.

Position: Contrast agents and biosensors for medical imaging and image-guided therapy We are seeking a researcher focused on the development of imaging contrast agents or other biosensor approaches that are relevant to the understanding, diagnosis or treatment of disease processes.The research focus can involve imaging modalities such as MRI, PET, optical and ultrasound, and it may relate to multimodal imaging.

Role and Responsibilities: Development of our core algorithm is guided by performance benchmarking on real and simulated data (to forecast future performance and what-if scenarios).To support this process, the role may include: Development of a reproducible performance benchmarking framework to track current and predicted quantitative accuracy, sensitivity, and precision.

We are seeking a versatile computational scientist to support clinical and research programs in the metabolic disease space.Taking a lead role in these studies, the successful candidate will communicate effectively with researchers and clinicians, and develop methods to interpret diverse data types.

The Broad Institute of MIT & Harvard, a world leader in cancer genome research, is looking for an exceptional candidate to join the Sellers lab.The successful candidate will join an interdisciplinary team of bioinformatics analysts and biologists who are working together to elucidate new therapeutic hypotheses and to develop novel cancer therapeutics.

We are seeking a self-motivated computational scientist who values independent research and new method development.The successful candidate will join an inspiring and collaborative bioinformatic team that uses multi-omics data to understand the mechanisms of antitumor immunity in the Immuno-Oncology (IO) space.

Company Description Hexagon Bio is leveraging its proprietary genomics-based platform and understanding of natural product evolution to develop the next generation of medicines for human disease.Hexagon Bio's algorithms identify biosynthetic gene clusters that encode the machinery needed to produce specialized metabolites that can be used to identify and modulate human disease targets.

Scientist, Computational Biology at Denali Therapeutics South San Francisco, CA Scientist, Computational Biology Denali Therapeutics is dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine.The Opportunity We are seeking to recruit a Computational Biologist to join our Discovery Genomics team to study the biology underlying neurodegeneration, with a particular focus on microglial biology and neuroinflammation.

Function/Duties of Position Every Knight Cancer employee is expected to embody our guiding principles: We act BOLDLYBreakthroughs require pushing the boundaries of science, exploring new frontiers, and thinking differently We SUPPORT each otherRespect leads to trust, which leads to excellence We work as a CONNECTED team We must leverage our collective brain power to conquer cancer because no one individual can do it alone Duties Include: Collaboration: Acts as the primary contact between IMCO and the mIHC and CyTOF platforms in terms of data generation and management.Interfaces with other members of the cores to streamline data management and generation including computational requirements and analysis interpretation.

The Role Rheos Medicines is looking for an exceptional individual to lead our Computational Biology and Translational Data Sciences effort at Rheos Medicines.This role is ideal for a highly collaborative individual that will be responsible to lead, develop and execute a transformative data and analytics strategy to accelerate target discovery and drug development in immuno-metabolism.

Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors.The companys broad platform harnesses single-cell technologies and machine learning to digitize and quantify cellular behaviors, unravel the network dynamics that govern those behaviors, and generate medicines that can direct them.

At Lilly, we unite caring with discovery to make life better for people around the world.We are a global healthcare leader headquartered in Indianapolis, Indiana.

We make healthy cells invisible to targeted therapies Targeted therapies work by attacking cells that express particular proteins on their surface.Unfortunately, both diseased and healthy cells often express the same proteins, resulting in collateral damage to healthy cells.

Computational Biologist, Cancer Biology About the Role As a Computational Biologist dedicated to Cancer Biology at Freenome, you will be key to the development of early, noninvasive tests for cancer detection.You will use a strong foundation in cancer biology to motivate hypotheses and drive improvements to our best-in class computational algorithms detecting molecular signatures of cancer.

Empress Therapeutics Inc. is an early stage biotechnology company founded by Flagship Pioneering.Empressis pioneering medicines based on a novel category of molecules that play a fundamental role in human-microbe communication.

About NNRCC NNRCC, founded in 1997, takes pride in being the first R&D centre established by a multinational pharmaceutical company in China that taps into the surrounding wealth of opportunities and talents in biomedical sciences.Its mission has aimed to become a centre of technological excellence and to forge collaborations among pharmaceutical companies, academic institutions, research entities, and hospitals.

At Johnson & Johnson, we use technology and the power of teamwork to discover new ways to prevent and overcome the worlds the most significant healthcare challenges.Our Corporate, Consumer Health, Medical Devices, and Pharmaceutical teams leverage data, real-world insights, and creative minds to make life-changing healthcare products and medicines.